228 related articles for article (PubMed ID: 21991353)
1. Engineering bispecificity into a single albumin-binding domain.
Nilvebrant J; Alm T; Hober S; Löfblom J
PLoS One; 2011; 6(10):e25791. PubMed ID: 21991353
[TBL] [Abstract][Full Text] [Related]
2. Engineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albumin.
Nilvebrant J; Åstrand M; Georgieva-Kotseva M; Björnmalm M; Löfblom J; Hober S
PLoS One; 2014; 9(8):e103094. PubMed ID: 25089830
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3.
Nilvebrant J; Astrand M; Löfblom J; Hober S
Cell Mol Life Sci; 2013 Oct; 70(20):3973-85. PubMed ID: 23728098
[TBL] [Abstract][Full Text] [Related]
4. Orthogonal protein purification facilitated by a small bispecific affinity tag.
Nilvebrant J; Alm T; Hober S
J Vis Exp; 2012 Jan; (59):. PubMed ID: 22297419
[TBL] [Abstract][Full Text] [Related]
5. Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension.
von Witting E; Lindbo S; Lundqvist M; Möller M; Wisniewski A; Kanje S; Rockberg J; Tegel H; Åstrand M; Uhlén M; Hober S
Mol Pharm; 2021 Jan; 18(1):328-337. PubMed ID: 33259222
[TBL] [Abstract][Full Text] [Related]
6. A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.
Kronqvist N; Löfblom J; Jonsson A; Wernérus H; Ståhl S
Protein Eng Des Sel; 2008 Apr; 21(4):247-55. PubMed ID: 18239074
[TBL] [Abstract][Full Text] [Related]
7. A small bispecific protein selected for orthogonal affinity purification.
Alm T; Yderland L; Nilvebrant J; Halldin A; Hober S
Biotechnol J; 2010 Jun; 5(6):605-17. PubMed ID: 20518064
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
[TBL] [Abstract][Full Text] [Related]
9. Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension.
Malm M; Bass T; Gudmundsdotter L; Lord M; Frejd FY; Ståhl S; Löfblom J
Biotechnol J; 2014 Sep; 9(9):1215-22. PubMed ID: 24678002
[TBL] [Abstract][Full Text] [Related]
10. Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling.
Gunneriusson E; Nord K; Uhlén M; Nygren P
Protein Eng; 1999 Oct; 12(10):873-8. PubMed ID: 10556248
[TBL] [Abstract][Full Text] [Related]
11. Engineering of a femtomolar affinity binding protein to human serum albumin.
Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
[TBL] [Abstract][Full Text] [Related]
12. Surface display of a single-domain antibody library on Gram-positive bacteria.
Fleetwood F; Devoogdt N; Pellis M; Wernery U; Muyldermans S; Ståhl S; Löfblom J
Cell Mol Life Sci; 2013 Mar; 70(6):1081-93. PubMed ID: 23064703
[TBL] [Abstract][Full Text] [Related]
13. Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn.
Gong R; Wang Y; Ying T; Dimitrov DS
PLoS One; 2012; 7(8):e42288. PubMed ID: 22879932
[TBL] [Abstract][Full Text] [Related]
14. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
15. Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats.
Miller A; Carr S; Rabbitts T; Ali H
MAbs; 2020; 12(1):1752529. PubMed ID: 32316838
[TBL] [Abstract][Full Text] [Related]
16. Fine affinity discrimination by normalized fluorescence activated cell sorting in staphylococcal surface display.
Löfblom J; Wernérus H; Ståhl S
FEMS Microbiol Lett; 2005 Jul; 248(2):189-98. PubMed ID: 15964717
[TBL] [Abstract][Full Text] [Related]
17. The assembly of single domain antibodies into bispecific decavalent molecules.
Stone E; Hirama T; Tanha J; Tong-Sevinc H; Li S; MacKenzie CR; Zhang J
J Immunol Methods; 2007 Jan; 318(1-2):88-94. PubMed ID: 17141798
[TBL] [Abstract][Full Text] [Related]
18. Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.
Bailey LJ; Sheehy KM; Hoey RJ; Schaefer ZP; Ura M; Kossiakoff AA
J Immunol Methods; 2014 Dec; 415():24-30. PubMed ID: 25450256
[TBL] [Abstract][Full Text] [Related]
19. A novel bispecific antibody targeting tumor necrosis factor α and ED-B fibronectin effectively inhibits the progression of established collagen-induce arthritis.
Liu M; Xie M; Jiang S; Liu G; Li L; Liu D; Yang X
J Biotechnol; 2014 Sep; 186():1-12. PubMed ID: 24992210
[TBL] [Abstract][Full Text] [Related]
20. Investigating affinity-maturation strategies and reproducibility of fluorescence-activated cell sorting using a recombinant ADAPT library displayed on staphylococci.
Åstrand M; Nilvebrant J; Björnmalm M; Lindbo S; Hober S; Löfblom J
Protein Eng Des Sel; 2016 May; 29(5):187-95. PubMed ID: 26984961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
